封面
市场调查报告书
商品编码
1654308

全球单位剂量製造市场:市场规模、份额、趋势分析(按采购方式、产品、最终用途和地区)、细分市场预测(2025-2030 年)

Unit Dose Manufacturing Market Size, Share Trends Analysis Report By Sourcing (In-house, Outsourcing), By Product (Liquid, Solid), By End-use (Independent Pharmacies, Long Term Care), By Region, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

单位剂量製造市场的成长与趋势:

根据Grand View Research, Inc.的最新报告,全球单位剂量製造市场规模预计到2030年将达到1506.1亿美元,2025年至2030年期间的复合年增长率为11.43%。

2020 年上半年市场成长停滞,但在 2020 年代年终开始復苏。这主要是因为使用单位剂量治疗 COVID-19,减少了处理和从同一瓶中倒出剂量所涉及的风险。

单位剂量配方有很多优点,包括易于识别药物和在给药前保护药物配方。如果容器完好且药物未使用,则可以重新处理和收集,而无需更改配方。最重要的优点是它允许管理正确的量并确保患者不超过规定的限度。

然而,COVID-19 疫情对医药市场产生了重大影响。在新冠疫情大流行的上半年,成长放缓,但到 2020年终市场开始復苏。在当前情况下,单位剂量製造具有优势,因为它可以降低处理和污染风险。单位剂量疫苗也在医院中广泛用于治疗 COVID-19 患者,以保护患者和医护人员,因为它们消除了病毒透过空气或直接接触传播的可能性。

单位剂量製造市场报告重点

  • 根据采购方式,外包部门在 2024 年占据最大的收益市场占有率,为 60.74%,占据市场主导地位。由于成本效益、专业性、灵活性、风险缓解和全球市场准入等原因,外包服务在单位剂量製造业中占据了主导地位。
  • 固态单位剂量部分在 2024 年占据市场最大收入份额,达 50.49%。锭剂和胶囊等固态单位剂量形式由于其需求量大、应用范围广和患者方便而占据单位剂量市场主导地位。
  • 根据最终用途,独立药局部门将在 2024 年以 39.11% 的最大收益占有率引领市场,并且预计在预测期内将以最快的复合年增长率成长。
  • 2024 年,北美占据单位剂量製造市场的主导地位,收益占有率最大,为 37.73%。该地区先进的医疗保健基础设施、高发病率的慢性病以及注重患者安全和用药准确性的严格法规正在推动市场收益的成长。

目录

第一章 分析方法及范围

第 2 章执行摘要

3. 单位剂量製造市场:驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 技术格局
  • 定价模式分析
  • 市场分析工具
    • 波特五力分析
    • PESTEL 分析
    • COVID-19影响分析

第 4 章单位剂量製造市场:按采购方法的估计和趋势分析

  • 细分仪表板
  • 单位剂量製造市场:以采购方式进行的变化分析
  • 依来源分类(2018-2030 年)
  • 内部
  • 外包

第 5 章单位剂量製造市场:按产品分類的估计和趋势分析

  • 细分仪表板
  • 单位剂量製造市场:按产品进行的变化分析
  • 按产品(2018 - 2030 年)
  • 液体单位剂量
  • 固态单位剂量
  • 其他的

6. 单位剂量製造市场:依最终用途的估计和趋势分析

  • 细分仪表板
  • 单位剂量製造市场:最终用途变化分析
  • 依最终用途分类(2018-2030 年)
  • 独立药房
  • 长期照护机构
  • 医院
  • 其他的

第 7 章单位剂量製造市场:区域估计与趋势分析

  • 各地区市场占有率分析(2024 年及 2030 年)
  • 市场仪表板:按地区
  • 全球市场概况:按地区
  • 北美洲
    • 市场估计和预测,
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 市场估计和预测,
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 丹麦
    • 挪威
  • 亚太地区
    • 市场估计和预测,
    • 日本
    • 中国
    • 印度
    • 泰国
    • 韩国
    • 澳洲
  • 拉丁美洲
    • 市场估计和预测,
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 市场估计和预测,
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 公司分类
    • 市场领导
    • 新兴企业
  • 2024 年企业市场分析(企业热图分析)
  • 公司简介
    • Catalent Inc.
    • Unither Pharmaceuticals
    • Thermo Fisher Scientific
    • Corden Pharma
    • Mikart
    • Tape Mark
    • Renaissance Lakewood LLC
    • Medical Packaging Inc
    • American Health Packaging
    • PCI Pharma Services
    • Amcor PLC
    • Bristol-Myers Squibb
    • AbbVie Inc.
    • Merck &Co. Inc.
    • Pfizer Inc.
Product Code: GVR-4-68039-695-9

Unit Dose Manufacturing Market Growth & Trends:

The global unit dose manufacturing market size is expected to reach USD 150.61 billion by 2030, registering a CAGR of 11.43% from 2025 to 2030, according to a new report by Grand View Research, Inc. In the first half of 2020, the growth of the market was stagnant, but the market started to recover by the end of 2020. It was mainly due to the use of unit doses for the treatment of COVID-19 as it decreases the risk involved while handling and pouring doses from the same bottle.

Unit dose manufacturing has many advantages as the drug can be easily identified, and the formulation of the drug is protected until the moment of administration. If the container is intact and the drug has not been used, it can be redisposed and retrieved without changing its formulation. The most important benefit is that it can be administered in the proper dosage and ensures that the patient does not exceed the prescribed limit.

However, the COVID-19 pandemic has a significant effect on the pharmaceutical market. The first half of the COVID-19 pandemic had slowed growth but by the end of 2020, the market started to recover. The unit dose manufacturing is lucratively used in the current scenario as it reduces the risk of handling and contamination. Also, unit doses are widely used in hospitals for COVID-19 patients to safeguard both patients and healthcare personnel to eliminate the possibility of viral transmission by airborne transmission or direct touch.

Unit Dose Manufacturing Market Report Highlights:

  • By sourcing, the outsourcing segment led the market with the largest revenue market share of 60.74% in 2024. Outsourcing services dominated the unit dose manufacturing industry, owing to cost-effectiveness, expertise, flexibility, risk reduction, and access to global markets.
  • The solid unit dose segment led the market with the largest revenue share of 50.49% in 2024. Solid unit dosage forms such as tablets and capsules dominate unit dose marketing due to their high demand, widespread applications, and patient convenience.
  • Based on end use, the independent pharmacies segment led the market with the largest revenue share of 39.11% in 2024 and is also anticipated to register at the fastest CAGR over the forecast period.
  • North America dominated the unit dose manufacturing market with the largest revenue share of 37.73% in 2024. The market revenue growth is driven by the region's advanced healthcare infrastructure, high prevalence of chronic diseases, and strong regulatory focus on patient safety and medication accuracy.

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Regional Scope
    • 1.1.2. Estimates And Forecast Timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Parent Market Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Unit Dose Manufacturing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increased Adoption of Unit Doses
      • 3.2.1.2. Benefits of Manufacturing Unit Doses Over Repackaging
      • 3.2.1.3. Growing Outsourcing Activities
      • 3.2.1.4. Technological Advancements in Unit Dose Manufacturing
      • 3.2.1.5. Increasing Prevalence of Chronic Diseases and Demand for Personalized Medicine
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Challenges Associated with the Adoption of Manufactured Unit Doses
      • 3.2.2.2. Compliance Issues with Outsourcing
  • 3.3. Technology Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. Market Analysis Tools
    • 3.5.1. Porter's Five Forces Analysis
    • 3.5.2. PESTEL Analysis
    • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Unit Dose Manufacturing Market: Sourcing Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Unit Dose Manufacturing Market: Sourcing Movement Analysis
  • 4.3. Unit Dose Manufacturing Market Estimates & Forecasts, by Sourcing, 2018 - 2030 (USD Million)
  • 4.4. In-House
    • 4.4.1. In-House Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Outsourcing
    • 4.5.1. Outsourcing Market Estimates & Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Unit Dose Manufacturing Market: Product Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Unit Dose Manufacturing Market: Product Movement Analysis
  • 5.3. Unit Dose Manufacturing Market Estimates & Forecasts, by Product, 2018 - 2030 (USD Million)
  • 5.4. Liquid Unit Dose
    • 5.4.1. Liquid Unit Dose Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Solid Unit Dose
    • 5.5.1. Solid Unit Dose Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Estimates & Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Unit Dose Manufacturing Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Unit Dose Manufacturing Market: End Use Movement Analysis
  • 6.3. Unit Dose Manufacturing Market Estimates & Forecasts, by End Use, 2018 - 2030 (USD Million)
  • 6.4. Independent Pharmacies
    • 6.4.1. Independent Pharmacies Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Long Term Care Facility
    • 6.5.1. Long Term Care Facility Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Hospitals
    • 6.6.1. Hospitals Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market Estimates & Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Unit Dose Manufacturing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. North America
    • 7.4.1. Market Estimates and Forecast, (Revenue, USD Million, 2018 - 2030)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Market Estimates and Forecast, (Revenue, USD Million, 2018 - 2030)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Market Estimates and Forecast, (Revenue, USD Million, 2018 - 2030)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Thailand
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Australia
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Market Estimates and Forecast, (Revenue, USD Million, 2018 - 2030)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. Market Estimates and Forecast, (Revenue, USD Million, 2018 - 2030)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
    • 8.1.1. Market Leaders
    • 8.1.2. Emerging Players
  • 8.2. Company Market Position Analysis, 2024 (Company Heat Map Analysis)
  • 8.3. Company Profiles
    • 8.3.1. Catalent Inc.
      • 8.3.1.1. Company Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Service Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Unither Pharmaceuticals
      • 8.3.2.1. Company Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Service Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Thermo Fisher Scientific
      • 8.3.3.1. Company Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Service Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Corden Pharma
      • 8.3.4.1. Company Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Service Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Mikart
      • 8.3.5.1. Company Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Service Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Tape Mark
      • 8.3.6.1. Company Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Service Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Renaissance Lakewood LLC
      • 8.3.7.1. Company Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Service Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Medical Packaging Inc
      • 8.3.8.1. Company Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Service Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. American Health Packaging
      • 8.3.9.1. Company Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Service Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. PCI Pharma Services
      • 8.3.10.1. Company Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Service Benchmarking
      • 8.3.10.4. Strategic Initiatives
    • 8.3.11. Amcor PLC
      • 8.3.11.1. Company Overview
      • 8.3.11.2. Financial Performance
      • 8.3.11.3. Service Benchmarking
      • 8.3.11.4. Strategic Initiatives
    • 8.3.12. Bristol-Myers Squibb
      • 8.3.12.1. Company Overview
      • 8.3.12.2. Financial Performance
      • 8.3.12.3. Service Benchmarking
      • 8.3.12.4. Strategic Initiatives
    • 8.3.13. AbbVie Inc.
      • 8.3.13.1. Company Overview
      • 8.3.13.2. Financial Performance
      • 8.3.13.3. Service Benchmarking
      • 8.3.13.4. Strategic Initiatives
    • 8.3.14. Merck & Co. Inc.
      • 8.3.14.1. Company Overview
      • 8.3.14.2. Financial Performance
      • 8.3.14.3. Service Benchmarking
      • 8.3.14.4. Strategic Initiatives
    • 8.3.15. Pfizer Inc.
      • 8.3.15.1. Company Overview
      • 8.3.15.2. Financial Performance
      • 8.3.15.3. Service Benchmarking
      • 8.3.15.4. Strategic Initiatives

List of Tables

  • Table. 1 Market segmentation
  • Table. 2 Market research process
  • Table. 3 Information procurement
  • Table. 4 Primary research pattern
  • Table. 5 Market research approaches
  • Table. 6 Value chain-based sizing & forecasting
  • Table. 7 QFD modelling for market share assessment
  • Table. 8 Market formulation & validation
  • Table. 9 Unit dose manufacturing market revenue, 2018 - 2030 (USD Million)
  • Table. 10 Unit dose manufacturing market snapshot
  • Table. 11 Unit dose manufacturing market driver impact
  • Table. 12 Unit dose manufacturing market restraint impact
  • Table. 13 Unit dose manufacturing sourcing key takeaways (USD Million)
  • Table. 14 Unit dose manufacturing market: Sourcing movement analysis
  • Table. 15 In-house market, 2018 - 2030 (USD Million)
  • Table. 16 Outsourcing market, 2018 - 2030 (USD Million)
  • Table. 17 Unit dose manufacturing market product key takeaways (USD Million)
  • Table. 18 Unit dose manufacturing market: Product movement analysis
  • Table. 19 Liquid unit dose market, 2018 - 2030 (USD Million)
  • Table. 20 Solid unit dose market, 2018 - 2030 (USD Million)
  • Table. 21 Others market, 2018 - 2030 (USD Million)
  • Table. 22 Unit dose manufacturing market end use key takeaways (USD Million)
  • Table. 23 Unit dose manufacturing market: End use movement analysis
  • Table. 24 Independent pharmacies market, 2018 - 2030 (USD Million)
  • Table. 25 Long term care facility market, 2018 - 2030 (USD Million)
  • Table. 26 Hospitals market, 2018 - 2030 (USD Million)
  • Table. 27 Others market, 2018 - 2030 (USD Million)
  • Table. 28 Regional marketplace: Key takeaways
  • Table. 29 Regional outlook, 2024 & 2030
  • Table. 30 North America unit dose manufacturing Market, 2018 - 2030 (USD Million)
  • Table. 31 U.S. unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 32 Canada unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 33 Mexico unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 34 Europe unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 35 UK unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 36 Germany unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 37 France unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 38 Italy unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 39 Spain unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 40 Sweden unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 41 Denmark unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 42 Norway unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 43 Asia Pacific unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 44 Japan unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 45 China unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 46 India unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 47 Thailand unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 48 South Korea unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 49 Australia unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 50 Latin America unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 51 Brazil unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 52 Argentina unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 53 Middle East & Africa unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 54 South Africa unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 55 Saudi Arabia unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 56 UAE unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 57 Kuwait unit dose manufacturing market, 2018 - 2030 (USD Million)
  • Table. 58 Market participant categorization

List of Figures

  • Fig. 1 List of Tables
  • Fig. 2 List of Secondary Sources
  • Fig. 3 List of Abbreviations
  • Fig. 4 Global Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 5 Global Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 6 Global Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 7 Global Unit Dose Manufacturing, by Region, 2018 - 2030 (USD Million)
  • Fig. 8 North America Unit Dose Manufacturing, by Country, 2018 - 2030 (USD Million)
  • Fig. 9 North America Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 10 North America Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 11 North America Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 12 U.S. Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 13 U.S. Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 14 U.S. Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 15 Canada Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 16 Canada Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 17 Canada Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 18 Mexico Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 19 Mexico Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 20 Mexico Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 21 Europe Unit Dose Manufacturing, by Country, 2018 - 2030 (USD Million)
  • Fig. 22 Europe Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 23 Europe Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 24 Europe Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 25 Germany Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 26 Germany Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 27 Germany Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 28 UK Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 29 UK Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 30 UK Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 31 France Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 32 France Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 33 France Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 34 Italy Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 35 Italy Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 36 Italy Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 37 Spain Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 38 Spain Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 39 Spain Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 40 Denmark Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 41 Denmark Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 42 Denmark Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 44 Sweden Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 45 Sweden Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 46 Norway Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 47 Norway Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 48 Norway Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 49 Asia Pacific Unit Dose Manufacturing, by Country, 2018 - 2030 (USD Million)
  • Fig. 50 Asia Pacific Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 51 Asia Pacific Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 52 Asia Pacific Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 53 China Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 54 China Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 55 China Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 56 Japan Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 57 Japan Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 58 Japan Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 59 India Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 60 India Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 61 India Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 62 South Korea Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 63 South Korea Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 64 South Korea Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 65 Australia Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 66 Australia Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 67 Australia Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 68 Thailand Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 69 Thailand Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 70 Thailand Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 71 Latin America Unit Dose Manufacturing, by Country, 2018 - 2030 (USD Million)
  • Fig. 72 Latin America Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 73 Latin America Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 74 Latin America Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 75 Brazil Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 76 Brazil Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 77 Brazil Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 78 Argentina Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 79 Argentina Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 80 Argentina Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 81 Middle East & Africa Unit Dose Manufacturing, by Country, 2018 - 2030 (USD Million)
  • Fig. 82 Middle East & Africa Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 83 Middle East & Africa Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 84 Middle East & Africa Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 85 South Africa Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 86 South Africa Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 87 South Africa Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 88 Saudi Arabia Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 89 Saudi Arabia Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 90 Saudi Arabia Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 91 UAE Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 92 UAE Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 93 UAE Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 94 Kuwait Unit Dose Manufacturing, by Sourcing, 2018 - 2030 (USD Million)
  • Fig. 95 Kuwait Unit Dose Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 96 Kuwait Unit Dose Manufacturing, by End Use, 2018 - 2030 (USD Million)